Published in Clin Sci Mol Med on August 01, 1978
Neuroendocrine markers of CNS drug effects. Br J Clin Pharmacol (1980) 0.87
Dopamine in the pituitary adaptation to starvation in man. Postgrad Med J (1985) 0.75
The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group. N Engl J Med (1998) 4.81
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Radioimmunoassay of human serum thyrotrophin. Br Med J (1971) 4.59
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques. Infect Immun (1988) 4.44
Thyrotrophin-releasing hormone as a thyroid-function test. Lancet (1971) 4.34
Grades of hypothyroidism. Br Med J (1973) 3.30
Vitiligo, thyroid disease and autoimmunity. Br J Dermatol (1968) 3.18
The thyrotrophin-releasing hormone test in diseases of the pituitary and hypothalamus. Lancet (1972) 3.10
Nucleotide sequence of the L-arabinose regulatory region of Escherichia coli K12. J Biol Chem (1978) 2.88
Thyroid-stimulating immunoglobulins in Graves' disease. Lancet (1974) 2.84
Major surface antigen gene of a human malaria parasite cloned and expressed in bacteria. Nature (1984) 2.74
Circulating sensitised lymphocytes in Graves' disease. Observations on its pathogenesis. Lancet (1970) 2.73
Conducting clinical research in the new NHS: the model of cancer. United Kingdom Coordinating Committee on Cancer Research. BMJ (1994) 2.70
Hopping hotspots: global shifts in marine biodiversity. Science (2008) 2.68
Inhibition of gastrin and gastric-acid secretion by growth-hormone release-inhibiting hormone. Lancet (1974) 2.65
Carbimazole and the autoimmune response in Graves' disease. N Engl J Med (1980) 2.62
The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer. J Clin Endocrinol Metab (2001) 2.61
A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group. N Engl J Med (1994) 2.58
Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs. Lancet (1975) 2.57
Aggregative adherence fimbria II, a second fimbrial antigen mediating aggregative adherence in enteroaggregative Escherichia coli. Infect Immun (1997) 2.50
Bromocriptine therapy in acromegaly. Lancet (1975) 2.42
Cyclosporin improves Graves' ophthalmopathy. Lancet (1983) 2.32
Treatment of hypothyroidism: a reappraisal of thyroxine therapy. Br Med J (1973) 2.30
Hyponatraemia, hypothyroidism, and role of arginine-vasopressin. Lancet (1997) 2.11
Antigens of the erythrocytes stages of the human malaria parasite Plasmodium falciparum detected by monoclonal antibodies. Mol Biochem Parasitol (1983) 2.00
Natural history of autoimmune thyroiditis. Br Med J (Clin Res Ed) (1981) 1.99
CDtool-an integrated software package for circular dichroism spectroscopic data processing, analysis, and archiving. Anal Biochem (2004) 1.96
Clinical pathology testing recommendations for nonclinical toxicity and safety studies. AACC-DACC/ASVCP Joint Task Force. Toxicol Pathol (1992) 1.94
Aggregative adherence fimbria I expression in enteroaggregative Escherichia coli requires two unlinked plasmid regions. Infect Immun (1993) 1.89
Association between postpartum thyroid dysfunction and thyroid antibodies and depression. BMJ (1992) 1.86
Dermoid cyst in the floor of the mouth. Review of the literature and case reports. Oral Surg Oral Med Oral Pathol (1994) 1.83
Letter: Complication of proximal gastric vagotomy. Br Med J (1974) 1.82
Trial of strategy for reducing the use of laboratory tests. Br Med J (Clin Res Ed) (1986) 1.82
Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2000) 1.82
Thyroid-stimulating hormone response to synthetic thyrotrophin releasing hormone in man. Br Med J (1970) 1.79
An enzyme-linked immunoassay for thyroid microsomal antibodies. J Immunol Methods (1982) 1.79
Effusions into body cavities in hypothyroidism. Lancet (1975) 1.77
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. J Bone Miner Res (2001) 1.76
Serum-thyrotropin levels after subtotal thyroidectomy for Graves' disease. Lancet (1971) 1.73
Effects of growth-hormone release-inhibiting hormone on circulating glucagon, insulin, and growth hormone in normal, diabetic, acromegalic, and hypopituitary patients. Lancet (1974) 1.71
Histology by magnetic resonance microscopy. Magn Reson Q (1993) 1.71
Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) (1981) 1.70
Prediction of outcome in Graves' disease after carbimazole treatment. Q J Med (1986) 1.68
Action of growth-hormone-release inhibitory hormone in healthy men and in acromegaly. Lancet (1973) 1.68
Dopamine agonists and pituitary tumor shrinkage. Endocr Rev (1992) 1.67
Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev Dyn (2000) 1.67
Luteinizing hormone and follicle stimulating hormone-releasing hormone test in patients with hypothalamic-pituitary-gonadal dysfunction. Br Med J (1973) 1.66
Effects of bromocriptine on pituitary tumour size. Br Med J (1979) 1.64
Alteration in connexin 43 gap junction gene dosage impairs conotruncal heart development. Dev Biol (1998) 1.64
Interaction between secretion of the gonadotrophins, prolactin, growth hormone, thyrotrophin and corticosteroids in man: the effects of LH FSH-RH, TRH and hypoglycaemia alone and in combination. Clin Endocrinol (Oxf) (1973) 1.60
Meningococcal disease in Wales: clinical features, outcome and public health management. J Infect (1992) 1.60
Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J (2002) 1.59
A systematic approach to erectile dysfunction in the cardiovascular patient: a Consensus Statement--update 2002. Int J Clin Pract (2002) 1.58
Treatment of hyperthyroidism by radioactive iodine. Summary of a UK national survey prepared for the Royal College of Physicians Committee on Endocrinology and Diabetes. J R Coll Physicians Lond (1992) 1.56
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. J Pharmacol Exp Ther (2001) 1.54
Thyroid-autoantibody synthesis by Hashimoto thyroid lymphocytes. Lancet (1979) 1.52
Immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in autoimmune adrenal diseases. Clin Chem (1995) 1.51
Ribosomal RNA sequences of Sarcocystis muris, Theileria annulata and Crypthecodinium cohnii reveal evolutionary relationships among apicomplexans, dinoflagellates, and ciliates. Mol Biochem Parasitol (1991) 1.51
A systematic approach to erectile dysfunction in the cardiovascular patient: a consensus statement. Int J Clin Pract (1999) 1.51
Confirming the drugs administered during anaesthesia: a feasibility study in the pilot National Health Service sites, UK. Br J Anaesth (2010) 1.50
Myopathy in acromegaly. Lancet (1970) 1.50
Lipid profiles and cardiovascular disease in the Whickham area with particular reference to thyroid failure. Clin Endocrinol (Oxf) (1977) 1.49
Smoking cessation: a consensus statement with special reference to primary care. Int J Clin Pract (2001) 1.48
Cloning of a human autoimmune response: preparation and sequencing of a human anti-thyroglobulin autoantibody using a combinatorial approach. Autoimmunity (1992) 1.47
The immunoassay of thyroid-stimulating hormone and its clinical applications. Clin Endocrinol (Oxf) (1972) 1.47
Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf) (1980) 1.46
Lymphocyte and monocyte subset changes during cardiopulmonary bypass: effects of aging and gender. J Lab Clin Med (1997) 1.46
Ovarian ultrasonography highlights precision of symptoms of ovulation as markers of ovulation. Br Med J (Clin Res Ed) (1986) 1.45
Venous thrombo-embolism following inferior petrosal sinus sampling in Cushing's disease. J Endocrinol Invest (2000) 1.44
Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Med Res Rev (2001) 1.43
DNA-based and alphavirus-vectored immunisation with prM and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology (1998) 1.42
An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol (Oxf) (1982) 1.42
Hypothyroidism. Br Med J (1972) 1.41
Biomechanical evaluation of new fixation devices for mandibular angle fractures. Int J Oral Maxillofac Surg (1997) 1.41
Early-morning hyperglycemia in IDDM. Acute effects of cholinergic blockade. Diabetes Care (1989) 1.41
Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest (1995) 1.40
Body composition derived from whole body counting of potassium in growth hormone-deficient adults: a possible low intracellular potassium concentration. J Clin Endocrinol Metab (1996) 1.40
Thyroid antibodies are produced by thyroid-derived lymphocytes. Clin Exp Immunol (1982) 1.39
Catheter ablation of the atrioventricular node using radiofrequency energy. Aust N Z J Med (1994) 1.39
Hypopituitarism after coronary artery bypass grafting. BMJ (1998) 1.39
Increase of surface Ia-like antigen expression on human monocytes independent of antigenic stimuli. J Immunol (1981) 1.39
Diagnostic dilemmas in Cushing's syndrome. Ann Clin Biochem (2000) 1.39
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial. Pediatrics (2001) 1.38
Dynamics of leukocyte-platelet adhesion in whole blood. Blood (1991) 1.38
Processing, polymorphism, and biological significance of P190, a major surface antigen of the erythrocytic forms of Plasmodium falciparum. Mol Biochem Parasitol (1984) 1.37
History of dermatology in Northern Ireland. Br J Dermatol (1970) 1.36
Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood (1992) 1.36
Characterization of myosin light chains from histochemically identified fibres of rabbit psoas muscle. FEBS Lett (1975) 1.35
Enterococcal superinfection and colonization with aztreonam therapy. Antimicrob Agents Chemother (1984) 1.35
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest (2000) 1.34
Thyroid autoantibody synthesis by cultures of thyroid and peripheral blood lymphocytes. I. Lymphocyte markers and response to pokeweed mitogen. Clin Exp Immunol (1983) 1.34